Non-invasive diagnosis of pulmonary hypertension: ESC/ERS Guidelines with Updated Commentary of the Cologne Consensus Conference 2011

doi:10.1016/S0167-5273(11)70488-0

International Journal of Cardiology

Volume 154, Supplement 1, December 2011, Pages S3-S12

https://doi.org/10.1016/S0167-5273(11)70488-0 Get rights and content

Abstract

The 2009 European Guidelines on Diagnosis and Treatment of Pulmonary Hypertension have been adopted for Germany. The guidelines contain detailed recommendations for the diagnosis of pulmonary hypertension. However, the practical implementation of the European Guidelines in Germany requires the consideration of several country-specific issues and already existing novel data. This requires a detailed commentary to the guidelines, and in some aspects an update already appears necessary. In June 2010, a Consensus Conference organized by the PH working groups of the German Society of Cardiology (DGK), the German Society of Respiratory Medicine (DGP) and the German Society of Pediatric Cardiology (DGPK) was held in Cologne, Germany. This conference aimed to solve practical and controversial issues surrounding the implementation of the European Guidelines in Germany. To this end, a number of working groups was initiated, one of which was specifically dedicated to the non-invasive diagnosis of pulmonary hypertension. This manuscript describes in detail the results and recommendations of the working group which were last updated in October 2011.

References (71)

SP Gaine et al.
Primary pulmonary hypertension
Lancet
(1998)
J Tongers et al.
Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension
Am Heart J
(2007)
DB Badesch et al.
Diagnosis and assessment of pulmonary arterial hypertension
J Am Coll Cardiol
(2009)
LG Rudski et al.
Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography
J Am Soc Echocardiogr
(2010)
A Reichelt et al.
Chronic thromboembolic pulmonary hypertension: evaluation with 64-detector row CT versus digital substraction angiography
Eur J Radiol
(2009)
JT Marcus et al.
Interventricular mechanical asyn-chrony in pulmonary arterial hypertension: left-to-right delay in peak shortening is related to right ventricular overload and left ventricular underfilling
J Am Coll Cardiol
(2008)
S Rich et al.
Antinuclear antibodies in primary pulmonary hypertension
J Am Coll Cardiol
(1986)
JW Chu et al.
High prevalence of autoimmune thyroid disease in pulmonary arterial hypertension
Chest
(2002)
HH Leuchte et al.
N-terminal pro-brain natriuretic peptide and renal insufficiency as predictors of mortality in pulmonary hypertension
Chest
(2007)
T Albrecht et al.
Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent
Lancet
(1999)

O Sitbon et al.

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival

J Am Coll Cardiol

(2002)

RJ Oudiz et al.

Cardiopulmonary exercise testing and six-minute walk correlations in pulmonary arterial hypertension

Am J Cardiol

(2006)

Y Yasunobu et al.

End-tidal PCO2 abnormality and exercise limitation in patients with primary pulmonary hypertension

Chest

(2005)

G Kovacs et al.

Assessment of pulmonary arterial pressure during exercise in collagen vascular disease: Echocardiography versus right heart catheterisation

Chest

(2010)

ML Alkotob et al.

Reduced exercise capacity and stress-induced pulmonary hypertension in patients with scleroderma

Chest

(2006)

V Steen et al.

Exercise-induced pulmonary arterial hypertension in patients with systemic sclerosis

Chest

(2008)

MA Voelkel et al.

Hyperuricemia in severe pulmonary hypertension

Chest

(2000)

A Fijalkowska et al.

Serum N-terminal brain na-triuretic peptide as a prognostic parameter in patients with pulmonary hypertension

Chest

(2006)

AK Andreassen et al.

N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension

Am J Cardiol

(2006)

RJ Raymond et al.

Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension

J Am Coll Cardiol

(2002)

C Tei et al.

Doppler echocardiographic index for assessment of global right ventricular function

J Am Soc Echocardiogr

(1996)

TC Yeo et al.

Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension

Am J Cardiol

(1998)

M Koestenberger et al.

Right ventricular function in infants, children and adolescents: Reference values of the tricuspid annular plane systolic excursion (TAPSE) in 640 healthy patients and calculation of z score values

J Am Soc Echocardiogr

(2009)

N Galiè et al.

Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)

Eur Heart J

(2009)

N Galiè et al.

Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)

Eur Respir J

(2009)

MM Hoeper et al.

Diagnosis and Treatment of Pulmonary Hypertension: European Guidelines 2009

Pneumologie

(2010)

S Rich et al.

Primary pulmonary hypertension. A national prospective study

Ann Intern Med

(1987)

MM Hoeper et al.

Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension

Eur Respir J

(2007)

MR Fisher et al.

Estimating pulmonary artery pressures by echocardiography in patients with emphysema

Eur Respir J

(2007)

E Hachulla et al.

Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study

Arthritis Rheum

(2005)

D Mukerjee et al.

Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis

Rheumatology

(2004)

D Launay et al.

Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease

J Rheumatol

(2007)

O Sitbon et al.

Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era

Am J Respir Crit Care Med

(2008)

E Grunig et al.

Stress Doppler echocardiography in relatives of patients with idiopathic and familial pulmonary arterial hypertension: results of a multicenter European analysis of pulmonary artery pressure response to exercise and hypoxia

Circulation

(2009)

D Bonderman et al.

A non-invasive algorithm to exclude precapillary pulmonary hypertension

Eur Respir J

(2011)

Cited by (59)

Prevalence of pulmonary hypertension in COPD patients living at high altitude
2022, Pulmonology
Pulmonary hypertension (PH) is associated with poor prognosis for patients with chronic obstructive pulmonary disease (COPD). Most of the knowledge about PH in COPD has been generated at sea level, with limited information associated with high altitude (HA).
To assess the prevalence and severity of PH in COPD patients living in a HA city (2,640 m).
Cross-sectional study in COPD patients with forced expiratory volume in the first second / forced vital capacity ratio (FEV₁/FVC) post-bronchodilator <0,7. Transthoracic echocardiography (TTE), spirometry, carbon monoxide diffusing capacity, and arterial blood gasses tests were performed. Patients were classified according to the severity of airflow limitation. PH was defined by TTE as an estimated systolic pulmonary artery pressure (sPAP) > 36 mmHg or indirect PH signs; severe PH as sPAP > 60 mmHg; and disproportionate PH as an sPAP > 60 mmHg with non-severe airflow limitation (FEV₁ > 50% predicted).
We included 176 COPD patients. The overall estimated prevalence of PH was 56.3% and the likelihood of having PH increased according to airflow-limitation severity: mild (31.6%), moderate (54.9%), severe (59.6%) and very severe (77.8%) (p = 0.038). The PH was severe in 7.3% and disproportionate in 3.4% of patients.
The estimated prevalence of PH in patients with COPD at HA is high, particularly in patients with mild to moderate airflow limitation, and greater than that described for COPD patients at low altitude. These results suggest a higher risk of developing PH for COPD patients living at HA compared to COPD patients with similar airflow limitation living at low altitude.
Correlation Between Doppler Echocardiography and Right Heart Catheterisation-Derived Systolic and Mean Pulmonary Artery Pressures: Determinants of Discrepancies Between the Two Methods
2021, Heart Lung and Circulation
There is still controversy about whether transthoracic echocardiography (TTE) can provide reliable estimations of pulmonary artery pressures (PAP). The primary endpoint of this study was to evaluate the correlation between TTE and right heart catheterisation (RHC) in estimating systolic (SPAP) and mean (MPAP) pulmonary artery pressures.
Between January 2011 and December 2018, 141 consecutive patients (average age 63.6±11.5 years; 84 women) with suspected or confirmed pulmonary hypertension (PH) were enrolled into this retrospective observational monocentric study. All patients underwent TTE and, within 3 hours, RHC. The correlation between TTE and RHC in estimating both SPAP and MPAP was retrospectively determined.
Seventeen (17) of the patients were excluded due to insufficient TTE signal quality. Of the remaining 124 patients, 18 had no PH. There was moderate correlation between both SPAP and MPAP estimated by TTE and those assessed by RHC (r=0.65 and r=0.60, respectively). Bland-Altman analysis revealed a bias of –11.9 mmHg (with the 95% limits of agreement ranging –45.4 to +21.5 mmHg) for SPAP estimation and –4.6 mmHg (with the 95% limits of agreement ranging –27.9 to +18.8 mmHg) for MPAP estimation, suggesting a general overestimation of PAP by TTE. The main factors responsible for discrepancies between TTE and RHC were: female gender, arrhythmic cardiac electrical activity, systemic arterial hypertension, and diuretic treatment.
Transthoracic echocardiography frequently overestimated PAP in comparison with RHC, especially in hypertensive women with arrhythmias and under diuretic treatment.
Usefulness of ventilatory gas analysis for the non-invasive evaluation of the severity of chronic thromboembolic pulmonary hypertension
2019, International Journal of Cardiology
Chronic thromboembolic pulmonary hypertension (CTEPH) is characterized by organic thrombotic obstructions in the pulmonary arteries with reduced pulmonary vascular reserve. This study aimed to examine whether postural changes in ventilatory gas analysis parameters are useful for assessing pulmonary hemodynamics in patients with CTEPH.
A total of 44 patients with newly diagnosed CTEPH (CTEPH group), 33 patients with improved CTEPH (mean pulmonary arterial pressure [mPAP] <25 mm Hg), and 25 controls were enrolled. Patients with improved CTEPH referred to patients without residual PH who were previously diagnosed with CTEPH and already received optimal therapies. Various pulmonary function parameters were examined in supine and sitting positions, and postural changes were calculated (Δ[supine − sitting]). In 32 patients with CTEPH, we examined hemodynamic and ventilatory gas analysis parameters before the first balloon pulmonary angioplasty (BPA) and during follow-up.
Patients with CTEPH had significantly lower supine end-tidal carbon dioxide pressure (P_ETCO₂) and ΔP_ETCO₂ than controls (both P < 0.001), and these parameters were significantly correlated with mPAP (R² = 0.507, P < 0.0001 and R² = 0.470, P < 0.001, respectively). Supine P_ETCO₂ and ΔP_ETCO₂ were significantly lower in patients with improved CTEPH than in controls (both P < 0.001). Hemodynamic and echocardiographic parameters were comparable in both groups. Furthermore, significant correlation between the change in mPAP and change in supine P_ETCO₂ by BPA was noted (R² = 0.478, P < 0.001).
These results indicate that postural changes in ventilatory gas analysis parameters are useful and non-invasive method for the evaluation of mPAP, which is one of the hemodynamic parameters of CTEPH severity.
Atrial chamber remodelling in healthy pre-adolescent athletes engaged in endurance sports: A study with a longitudinal design. The CHILD study
2016, International Journal of Cardiology
Citation Excerpt :
Longer-term effect of swimming on biatrial structure and function remains to be determined, along with age related changes in cardiac structure and function. This longitudinal study demonstrates that biatrial remodelling is dynamic in its nature and changes after training, the knowledge of this biatrial adaptation is relevant, when considering biatrial size as a marker for cardiac anatomical and functional pathology [33] or for raising the suspicion of a pulmonary hypertension independent of tricuspid regurgitation velocity [34]. The slight reduction in atrial deformation parameters should not be seen as pathological since it accompanied the enlargement of the atrial cavity, thus could easily be explained on the basis of Frank-Starling law, and its recovery which contributed to a normal ejection fraction supports its physiological nature.
Previous studies investigated the exercise-induced adaptation of left (LA) and right atrium (RA) in adults, but little is known about respective changes in the growing heart of children. We aimed to longitudinally investigate the effects of endurance training on biatrial remodelling in preadolescent athletes.
Ninety-four children (57 endurance athletes, 37 sedentary controls; mean age 10.8 ± 0.2 and 10.2 ± 0.2 years, respectively) were evaluated at baseline and after 5 months by ECG and by two-dimensional, three-dimensional (3D) and speckle-tracking echocardiography. Athletes were trained at least 10 h/week. The resting heart rate was lower in athletes (p = 0.046) and decreased further after training (p < 0.0001). Neither athletes nor controls had ECG evidence for LA or RA enlargement. At baseline, indexed LA volumes did not differ between groups (p = 0.14) but indexed RA dimensions were larger in athletes (p = 0.007). After 5 months, indexed LA volumes increased in athletes but not in controls (p < 0.0001, p = 0.29; respectively) while indexed RA volumes increased in both groups (p < 0.0001, p = 0.018; respectively). At the same time, slight differences in biatrial reservoir and contractile function were found either in athletes, as demonstrated by speckle-tracking echocardiography, but 3D-derived LA and RA ejection fraction remained stable in both groups.
Endurance training influences the growing heart of preadolescent athletes with an additive increase in biatrial size, suggesting that morphological adaptations can occur also in the early phases of the sports career. Training-induced remodelling was associated with a preserved biatrial function, supporting the hypothesis of a physiological remodelling.
A Phase-2 Exploratory Randomized Controlled Trial of INOpulse in Patients with Fibrotic Interstitial Lung Disease Requiring Oxygen
2022, Annals of the American Thoracic Society
Prognostic value of computed tomography derived measurements of pulmonary artery diameter for long-term outcomes after transcatheter aortic valve replacement
2022, Kardiologia Polska

View all citing articles on Scopus

: Source: Grünig E, Barner A, Bell M, et al. Non-invasive diagnosis in pulmonary hypertension:ESC/ERS guidelines with commentary of the Cologne ConsensusConference 2010. Dtsch Med Wochenschr 2010;135(Suppl3):S67-S77.

View full text

Non-invasive diagnosis of pulmonary hypertension: ESC/ERS Guidelines with Updated Commentary of the Cologne Consensus Conference 2011

Abstract

Lancet

Am Heart J

J Am Coll Cardiol

J Am Soc Echocardiogr

Eur J Radiol

J Am Coll Cardiol

J Am Coll Cardiol

Chest

Chest

Lancet

J Am Coll Cardiol

Am J Cardiol

Chest

Chest

Chest

Chest

Chest

Chest

Am J Cardiol

J Am Coll Cardiol

J Am Soc Echocardiogr

Am J Cardiol

J Am Soc Echocardiogr

Eur Heart J

Eur Respir J

Diagnosis and Treatment of Pulmonary Hypertension: European Guidelines 2009

Pneumologie

Primary pulmonary hypertension. A national prospective study

Ann Intern Med

Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension

Eur Respir J

Estimating pulmonary artery pressures by echocardiography in patients with emphysema

Eur Respir J

Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study

Arthritis Rheum

Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis

Rheumatology

Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease

J Rheumatol

Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era

Am J Respir Crit Care Med

Stress Doppler echocardiography in relatives of patients with idiopathic and familial pulmonary arterial hypertension: results of a multicenter European analysis of pulmonary artery pressure response to exercise and hypoxia

Circulation

A non-invasive algorithm to exclude precapillary pulmonary hypertension

Eur Respir J